SCOPUS 정보 검색 플랫폼

Journal of the National Cancer Institute

Volumn 94, Issue 4, 2002, Pages 291-297

Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer

(9) Ramsey, Scott D a,f Moinpour, Carol M a Lovato, Laura C a Crowley, John J a Grevstad, Patra b Presant, Cary A c Rivkin, Saul E b Kelly, Karen d Gandara, David R e

a SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER (United States)

b SWEDISH MEDICAL CENTER (United States)

c ST VINCENT MEDICAL CENTER (United States)

d UNIVERSITY OF COLORADO (United States)

e UNIVERSITY OF CALIFORNIA (United States)

f Fred Hutchinson Cancer Research Center (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG EFFICACY; FEMALE; HEALTH SERVICE; HOSPITAL PATIENT; HUMAN; LUNG NON SMALL CELL CANCER; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; STANDARDIZATION;

EID: 0037138736 PISSN: 00278874 EISSN: None Source Type: Journal
DOI: 10.1093/jnci/94.4.291 Document Type: Article

Times cited : (68)

References (29)

1
- 0034999148
- The burden of illness of cancer: Economic cost and quality of life
- (2001) Annu. Rev. Public Health , vol.22 , pp. 91-113
- Brown, M.L.¹ Lipscomb, J.² Snyder, C.³

2
- 0035397994
- Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced nonsmall-cell lung cancer: A Southwest Oncology Group trial
- (2001) J. Clin. Oncol. , vol.19 , pp. 3210-3218
- Kelly, K.¹ Crowley, J.² Bunn P.A., Jr.³ Presant, C.A.⁴ Grevstad, P.K.⁵ Moinpour, C.M.⁶

3
- 0029042825
- Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
- (1995) Lung Cancer , vol.12 , pp. 199-220
- Cella, D.F.¹ Bonomi, A.E.² Lloyd, S.R.³ Tulsky, D.S.⁴ Kaplan, E.⁵ Bonomi, P.⁶

4
- 0024996201
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer
- (1990) J. Clin. Oncol. , vol.8 , pp. 1301-1309
- Jaakkimainen, L.¹ Goodwin, P.J.² Pater, J.³ Warde, P.⁴ Murray, N.⁵ Rapp, E.⁶

5
- 0003469046
- Cost-effectiveness in health and medicine
- New York (NY): Oxford University Press
- (1996)
- Gold, M.R.¹ Siegal, J.E.² Russell, L.B.³ Weinstein, M.C.⁴

6
- 0003090227
- Linear regression analysis of censored medical costs
- (2000) Biostatistics , vol.1 , pp. 35-47
- Lin, D.Y.¹

7
- 0032011242
- On estimating costs for economic evaluation in failure time studies
- (1998) Med. Care , vol.36 , pp. 433-436
- Hallstrom, A.P.¹ Sullivan, S.D.²

8
- 0030910046
- Estimating medical costs from incomplete follow-up data
- (1997) Biometrics , vol.53 , pp. 419-434
- Lin, D.Y.¹ Feuer, E.J.² Etzioni, R.³ Wax, Y.⁴

9
- 0033050856
- On the use of survival analysis techniques to estimate medical care costs
- (1999) J. Health. Econ. , vol.18 , pp. 365-380
- Etzioni, R.D.¹ Feuer, E.J.² Sullivan, S.D.³ Lin, D.⁴ Hu, C.⁵ Ramsey, S.D.⁶

10
- 0008585067
- Comparison of quality of life (QOL) outcomes for two chemotherapy regimens in non-small cell lung cancer (NSCLC)
- (2000) Lung Cancer , vol.29 , Issue.SUPPL. 1 , pp. 34
- Moinpour, C.M.¹ Lyons, B.² Lovato, L.C.³ Grevstad, P.⁴ Kelly, K.⁵ Crowley, J.⁶

11
- 85037299632
- Quality of life in advanced non-small cell lung cancer: Results of a Southwest Oncology Group randomized trial
- [In press].
- Qual. Life Res
- Moinpour, C.M.¹ Lyone, B.² Grevstad, P.K.³ Lovato, L.C.⁴ Crowley, J.⁵ Czaplicki, K.⁶

12
- 0037616996
- SEER cancer statistics review, 1973-1996
- NIH Publ. No. 99-2789. Bethesda (MD): National Cancer Institute
- (1999)
- Ries, L.A.¹ Kosary, C.L.² Hankey, B.F.³ Miller, B.A.⁴ Clegg, L.⁵ Edwards, B.K.⁶

13
- 0029143976
- Free-riding and the prisoner's dilemma: Problems in funding economic analyses of phase III cancer clinical trials
- (1995) J. Clin. Oncol. , vol.13 , pp. 2457-2463
- Bennett, C.L.¹ Smith, T.J.² George, S.L.³ Hillner, B.E.⁴ Fleishman, S.⁵ Niell, H.B.⁶

14
- 0028074701
- The journal's policy on cost-effectiveness analyses
- (1994) N. Engl. J. Med. , vol.331 , pp. 669-670
- Kassirer, J.P.¹ Angell, M.²

15
- 0032724035
- Evaluation of conflict of interest in economic analyses of new drugs used in oncology
- (1999) JAMA , vol.282 , pp. 1453-1457
- Friedberg, M.¹ Saffran, B.² Stinson, T.J.³ Nelson, W.⁴ Bennett, C.L.⁵

16
- 0026533982
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease
- (1992) Ann. Intern. Med. , vol.116 , pp. 177-182
- Gulati, S.C.¹ Bennett, C.L.²

17
- 0033966393
- Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: A case for prospective economic analysis in cooperative group trials
- (2000) Med. Pediatr. Oncol. , vol.34 , pp. 92-96
- Bennett, C.L.¹ Stinson, T.J.² Lane, D.³ Amylon, M.⁴ Land, V.J.⁵ Laver, J.H.⁶

18
- 0033061781
- Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia
- Eastern Cooperative Oncology Group (E1490).
- (1999) Ann. Oncol. , vol.10 , pp. 177-182
- Bennett, C.L.¹ Stinson, T.J.² Tallman, M.S.³ Stadtmauer, E.A.⁴ Marsh, R.W.⁵ Friedenberg, W.⁶

19
- 0030901774
- Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia
- (1997) N. Engl. J. Med. , vol.336 , pp. 1781-1787
- Pui, C.H.¹ Boyett, J.M.² Hughes, W.T.³ Rivera, G.K.⁴ Hancock, M.L.⁵ Sandlund, J.T.⁶

20
- 0026344568
- Economic analysis alongside clinical trials. Revisiting the methodological issues
- (1991) Int. J. Technol. Assess. Health Care , vol.7 , pp. 561-573
- Dummond, M.F.¹ Davies, L.²

21
- 0031909956
- Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials
- (1998) Int. J. Technol. Assess. Health Care , vol.14 , pp. 135-144
- Coyle, D.¹ Davies, L.² Drummond, M.F.³

22
- 0031610833
- Integrating economic analysis into cancer clinical trials: The National Cancer Institute-American Society of Clinical Oncology economics workbook
- (1998) J. Natl. Cancer Inst. Monogr. , vol.24 , pp. 1-28

23
- 0030882072
- Economic analyses in clinical trials for cooperative groups: Operational considerations
- (1997) Cancer Invest. , vol.15 , pp. 448-453
- Bennett, C.L.¹ Waters, T.M.²

24
- 0033583765
- Incremental costs of enrolling cancer patients in clinical trials: A population-based study
- (1999) J. Natl. Cancer Inst. , vol.91 , pp. 847-853
- Wagner, J.L.¹ Alberts, S.R.² Sloan, J.A.³ Cha, S.⁴ Killian, J.⁵ O'Connell, M.J.⁶

25
- 0034684960
- Cost of care for patients in cancer clinical trials
- (2000) J. Natl. Cancer Inst. , vol.92 , pp. 136-142
- Fireman, B.H.¹ Fehrenbacher, L.² Gruskin, E.P.³ Ray, G.T.⁴

26
- 0033868088
- Evaluating the financial impact of clinical trials in oncology: Results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project
- (2000) J. Clin. Oncol. , vol.18 , pp. 2805-2810
- Bennett, C.L.¹ Stinson, T.J.² Vogel, V.³ Robertson, L.⁴ Leedy, D.⁵ O'Brien, P.⁶

27
- 0003413125
- Extending Medicare reimbursement in clinical trials
- Washington (DC): Institute of Medicine, National Academy Press
- (2000)
- Aaron, H.J.¹ Gellband, H.²

28
- 0002940740
- How drug makers influence Medicare reimbursements to doctors
- Sept
- (2000) The Wall Street Journal , vol.27
- Cloud, D.J.¹ McGinley, L.²

29
- 0029099339
- Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer
- (1995) J. Clin. Oncol. , vol.13 , pp. 2166-2173
- Smith, T.J.¹ Hillner, B.E.² Neighbors, D.M.³ McSorley, P.A.⁴ Le Chevalier, T.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.